Macrolide Compound Patent Application, Institute of Feed Research, Chinese Academy of Agricultural Science
Summary
The USPTO has published patent application US20260108549A1 for a macrolide compound, filed by the Institute of Feed Research under the Chinese Academy of Agricultural Sciences, with inventors Xiubo LI, Fei XU, Yiming LIU, and Xiaojie CHEN. The application, filed May 31, 2024, covers pharmaceutical and veterinary compositions containing the macrolide compound for treating pathogen infections, especially in animals. Patent applications are published to establish priority and allow public review of the invention.
“The macrolide compound, veterinary pharmaceutical composition and pharmaceutical preparation can be used to treat pathogen infections, especially to treat pathogen infections in animals, with a significant effect.”
About this source
USPTO classification A61K covers pharmaceutical preparations: formulations, dosage forms, combination therapies, delivery systems, and the vehicles that carry active ingredients. Every newly published application in A61K lands in this feed, around 245 a month. Applications publish 18 months after filing, so this feed reveals what pharma formulators at major sponsors and generics were working on in the prior year and a half. Watch this if you compete in drug formulation, file freedom-to-operate analyses, scout competitive drug products before clinical readouts, or follow novel delivery platforms like nanoparticles, lipid carriers, and long-acting injectables.
What changed
The USPTO published a new patent application (A1 publication) for a macrolide compound with pharmaceutical and veterinary applications. The application includes claims to the compound structure, preparation methods, and compositions for treating pathogen infections in animals.
Pharmaceutical and drug manufacturers reviewing this publication should note this represents a newly published application establishing filing priority for a macrolide antibiotic compound with potential veterinary and pharmaceutical applications. No immediate compliance obligations arise from this publication; the patent application does not yet grant exclusive rights and does not create regulatory requirements for other market participants.
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
MACROLIDE COMPOUND AND PREPARATION METHOD AND APPLICATION THEREOF
Application US20260108549A1 Kind: A1 Apr 23, 2026
Assignee
INSTITUTE OF FEED RESEARCH, CHINESE ACADEMY OF AGRICULTURAL SCIENCE
Inventors
Xiubo LI, Fei XU, Yiming LIU, Xiaojie CHEN
Abstract
A macrolide compound and a preparation method and application thereof are provided. The macrolide compound has a structure represented by Formula I. A pharmaceutical composition or a veterinary pharmaceutical composition, which includes the macrolide compound with a structure represented by Formula I, is also provided. Moreover, a pharmaceutical preparation, which includes the macrolide compound with a structure represented by Formula I, is provided. The macrolide compound, veterinary pharmaceutical composition and pharmaceutical preparation can be used to treat pathogen infections, especially to treat pathogen infections in animals, with a significant effect.
CPC Classifications
A61K 31/7048 A61P 31/04 C07H 17/08
Filing Date
2024-05-31
Application No.
19469376
Related changes
Get daily alerts for USPTO Patent Applications - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.